Skip to content
AwardedSpainGoods€2,589,370

2025-106 - Suministro de reactivos Prosigna para el análisis de la firma de expresión génica PAM50 con valor pronóstico para el manejo del cáncer de mama para el Laboratorio Core de Biología Molecular en el Hospital Clínic de Barcelona (HCB).

Published
Published 20 February 2026

Overview

Suministro de reactivos Prosigna para el análisis de la firma de expresión génica PAM50 con valor pronóstico para el manejo del cáncer de mama para el Laboratorio Core de Biología Molecular en el Hospital Clínic de Barcelona (HCB).

Key details

Country
Spain
Status
Awarded
Category
Goods
Estimated value
€2,589,370
Procedure
Open
Published
20 February 2026
Classification (CPV)
Laboratory reagents

Award outcome

Awarded value
€575,404
Award date
19 December 2025
Contract period
3 February 2026 → 2 February 2027
Winner
  • VERACYTE INC

Contract ending soon? Skim tracks incumbents and flags recompetes early. Book a demo to set up alerts.

Notice history

Every published notice in this contracting process, newest first.

  1. Contract Award Notice

    20 February 2026

Contracting authority

Get the full picture

AI analysis, bid scoring, and expert strategy for this tender

Skim analyses every tender against your company profile and tells you whether to bid, how to win, and who you are up against.

See which competitors are winning the contracts you're chasing.

15-minute call. We'll pull the win data on your real pipeline and show you what Skim does with it.

Awarded: 2025-106 - Suministro de reactivos Prosigna para el análisis de la firma de expresión génica PAM50 con valor pronóstico para el manejo del cáncer de mama para el Laboratorio Core de Biología Molecular en el Hospital Clínic de Barcelona (HCB). — won by VERACYTE INC — Skim